XML 12 R3.htm IDEA: XBRL DOCUMENT v3.23.3Close
Condensed Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Oct. 31, 2023
Oct. 31, 2022
Oct. 31, 2023
Oct. 31, 2022
Revenues:        
Total revenues $ 8,720 $ 7,837 $ 25,570 $ 22,968
Cost of revenues:        
Total cost of revenues [1],[2] 2,155 2,088 6,393 6,260
Gross profit 6,565 5,749 19,177 16,708 Close
Operating expenses:        
Research and development [1],[2] 1,204 1,280 3,631 3,927
Marketing and sales [1],[2] 3,173 3,345 9,440 10,141
General and administrative [1],[2] 632 664 1,902 1,967
Restructuring 55 0 815 [1],[2] 0 [1],[2]
Total operating expenses [1],[2] 5,064 5,289 15,788 16,035 Close
Income from operations 1,501 460 3,389 673 Close
Gains (losses) on strategic investments, net (72) 23 (242) 75 Close
Other income (expense) 58 (8) 158 (121) Close
Total Other Income Expenses -14.0 15.0 -84.0 0.0 -46.0 Close
Income before provision for income taxes 1,487 475 3,305 627 CloseClose
Provision for income taxes (263) (265) (615) (321) Close
Net income $ 1,224 $ 210 $ 2,690 $ 306 Close
Basic net income per share (in dollars per share) $ 1.26 $ 0.21 $ 2.76 $ 0.31
Diluted net income per share (in dollars per share) $ 1.25 $ 0.21 $ 2.73 $ 0.31
Shares used in computing basic net income per share (in shares) 972 997 976 995
Shares used in computing diluted net income per share (in shares) 981 1,000 985 1,001
Subscription and support        
Revenues:        
Total revenues $ 8,141 $ 7,233 $ 23,789 $ 21,232
Cost of revenues:        
Total cost of revenues [1],[2] 1,571 1,451 4,596 4,381
Professional services and other        
Revenues:        
Total revenues 579 604 1,781 1,736
Cost of revenues:        
Total cost of revenues [1],[2] $ 584 $ 637 $ 1,797 $ 1,879
[1] Amounts include amortization of intangible assets acquired through business combinations, as follows:
Three Months Ended October 31,Nine Months Ended October 31,
2023202220232022
Cost of revenues$245 $250 $743 $785 
Marketing and sales223 224 668 693 
[2] Amounts include stock-based compensation expense, as follows:
 Three Months Ended October 31,Nine Months Ended October 31,
 2023202220232022
Cost of revenues$109 $130 $324 $372 
Research and development238 287 735 863 
Marketing and sales275 330 815 947 
General and administrative71 96 223 288 
Restructuring 0 0 16 0